A cell biologist shares the wonder of researching life's most fundamental form
Physician Siddhartha Mukherjee explains how cellular science could lead to breakthroughs in the treatment of cancer, HIV, Type 1 diabetes and sickle cell anemia. His new book is The Song of the Cell.(Image credit: Simon & Schuster) (Source: NPR Health and Science)
Source: NPR Health and Science - November 21, 2022 Category: Consumer Health News Authors: Terry Gross Source Type: news
Tanzania: Quality Healthcare for Sickle Cell Patients
[Daily News] Zanzibar -- The Ministry of Health has formed a partnership with other health organisations to ensure quality healthcare to sickle cell patients. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 18, 2022 Category: African Health Source Type: news
Ghana: Airteltigo, ISCC Launch Sickle Cell Educational Campaign in Accra
[Ghanaian Times] Telecommu-nications network, AirtelTigo in partnership with the Internation-al Sickle Cell Centre (ISCC) yesterday launched a sickle cell educational campaign in Accra. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 16, 2022 Category: African Health Source Type: news
Hydroxyurea (also known as hydroxycarbamide) for people with sickle cell disease
Monday, November 14, 2022 (Source: Cochrane News and Events)
Source: Cochrane News and Events - November 14, 2022 Category: Information Technology Authors: Paolo Rosati Source Type: news
Lab-grown blood gives hope, says sickle cell patient
The aim is to help those with ultra-rare blood groups who need regular transfusions. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 10, 2022 Category: Consumer Health News Source Type: news
Two teaspoons of lab-made blood could have enormous potential for people with rare blood conditions
Scientists have transfused lab-made red blood cells into a human volunteer in a world-first trial that experts say has major potential for people with hard-to-match blood types or conditions such as sickle cell disease. The research could someday mean an end to long searches for compatible donors or dangerous transfusion reactions. (Source: CNN.com - Health)
Source: CNN.com - Health - November 9, 2022 Category: Consumer Health News Source Type: news
Groundbreaking clinical trial gives lab-grown red blood cells to people for the first time
A world-first clinical trial funded and supported by NIHR has started giving lab-grown red blood cells to people. If proved safe and effective, the technology could revolutionise treatments for people with rare blood types, blood disorders such as sickle cell, or people who aren ' t able to have normal blood transfusions. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 8, 2022 Category: Consumer Health News Source Type: news
Lab-grown blood cells give hope to donor patients after they are successfully transfused
The red blood cells, which take three weeks to create in a laboratory, could be a lifeline for people with advanced cancer or sickle cell disease. (Source: the Mail online | Health)
Source: the Mail online | Health - November 7, 2022 Category: Consumer Health News Source Type: news
New hope for sickle cell patients as UK trial of lab grown red blood cells begins
World first clinical test could be good news for people with rare blood groups and those who need frequent transfusionsLaboratory grown red blood cells have been transfused into volunteers in a world first clinical trial that could help revolutionise treatments for patients with sickle cell disease and thalassemia.The manufactured blood cells were grown from stem cells from donors, which in future could allow donor blood to be expanded into much larger volumes for transfusion. The trial is studying the lifespan of the lab grown cells compared with infusions of standard red blood cells from the same donor.Continue reading.....
Source: Guardian Unlimited Science - November 7, 2022 Category: Science Authors: Hannah Devlin Science correspondent Tags: Medical research Sickle cell disease Science Society NHS University of Bristol UK news Source Type: news
Post-Roe, Pregnant SCD Patients Facing'Dire' Risks Post-Roe, Pregnant SCD Patients Facing'Dire' Risks
Women with sickle cell disease have high-risk pregnancies with significant potential for health crises and death; physicians are concerned that tighter restrictions on abortions may compromise their care.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 1, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
CIRM grant will help expand patients ’ access to UCLA clinical trials for stem cell, gene therapies
A five-year, $8 million grant from the California Institute for Regenerative Medicine will enable UCLA stem cellscientists to include a wider cross-section of Los Angeles ’ diverse population in potentially lifesaving medical research.In part, the grant will fund the UCLA Alpha Stem Cell Clinic ’s continued collaboration with theUCLA Clinical and Translational Science Institute, which supports more than 350 clinical trials at medical centers and community clinics throughout the region.“Integrating the Alpha Stem Cell Clinic and Clinical and Translational Science Institute enables the university to build on the breadt...
Source: UCLA Newsroom: Health Sciences - October 27, 2022 Category: Universities & Medical Training Source Type: news
Dizziness, falls, and hearing loss in adults living with sickle cell disease - Nelson MD, Bennett DM, Lehman ME, Okonji AI.
OBJECTIVE: The aim of this study was to assess the prevalence of reported dizziness/imbalance, frequency of falls, and hearing loss in adults with sickle cell disease (SCD) and determine the relationship of these self-reported problems both during and in t... (Source: SafetyLit)
Source: SafetyLit - October 20, 2022 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Pfizer completes acquisition of Global Blood Therapeutics
Pfizer Inc. (NYSE: PFE) announced the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities starting with sickle cell disease (SCD). (Source: World Pharma News)
Source: World Pharma News - October 12, 2022 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news
SURVEILLANCE SUMMARIES: Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018
This report describes a program to characterize epidemiology of sickle cell disease in two states. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - October 6, 2022 Category: American Health Tags: Anemia Blood Disorders MMWR Morbidity & Mortality Weekly Report Sickle Cell Disease (SCD) Surveillance Source Type: news
Sickle cell: Black donors urged to give blood to help treat patients
Demand is at record levels for blood to help people with the disease that mostly affects black people. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 6, 2022 Category: Consumer Health News Source Type: news
